| 產(chǎn)品編號(hào) | bs-41455P |
| 英文名稱(chēng) | Recombinant SARS-Cov-2 Spike S1 protein (69/70 deletion, 144Y deletion, N501Y, A570D, D614G, P618H, hFc-(100-330aa), hFc (HEK293) |
| 中文名稱(chēng) | 重組SARS冠狀病毒2 Spike突變蛋白S1（69/70 deletion，144Y deletion，N501Y, A570D, D614G, P618H） |
| 別 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(69/70 deletion，144Y deletion，N501Y, A570D, D614G, P618H), Recombinant (hFc Tag); Recombinant SARS-Cov-2 Spike S1 protein (69/70 deletion, 144Y deletion, N501Y, A570D, D614G, P618H, hFc-(100-330aa), hFc (HEK293) 型新冠蛋白; 新冠病毒S蛋白突變體（69/70 deletion，144Y deletion，N501Y, A570D, D614G, P618H）; 重組新冠病毒 Spike突變蛋白S1(69/70 deletion，144Y deletion，N501Y, A570D, D614G, P618H); 新型冠狀病毒Spike突變體蛋白. |
| 克 隆 號(hào) | |
| 理論分子量 | 103 kDa |
| 檢測(cè)分子量 | 150-180 |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | ＞0.5 mg/ml |
| 物 種 | SARS-Cov-2 |
| 序 列 | 14-685/1273 |
| 純 度 | >95% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內(nèi)毒素 | Not analyzed |
| 表達(dá)系統(tǒng) | HEK293 cell |
| 活性 | Yes |
| 標(biāo)簽 | hFc |
| 緩 沖 液 | PBS (pH7.4). |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
| 產(chǎn)品圖片 |
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
|
